Sangamo BioSciences | SGMO - Activos Circulantes





Activos Circulantes Cambio Fecha
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Bayer EUR 32.91B 30M 2025-12
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
J&J USD 55.62B 1.01B 2025-12
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 46.92B 3.22B 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 3.09B 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12